Literature DB >> 14670336

The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector.

Luci P Maccormac1, Jean Marc Jacque, Benjamin Chain.   

Abstract

The Nef gene is a major determinant of HIV-1 pathogenicity. Several immunomodulatory functions have been reported for Nef, including down-regulation of CD4 and class I MHC in T-lymphocytes, and the ability to enhance viral transmission from macrophages and dendritic cells (DC) to T-lymphocytes. In this study, HIV-1 (SF2 strain) Nef was expressed in human monocyte-derived dendritic cells, using an adenovirus based delivery system. Nef expression resulted in decreased CD4 levels, but no change to class I MHC, and no impairment in the ability of DC to stimulate recall PPD responses, mixed leukocyte responses, or hepatitis B-specific CD8 responses. The adenovirus vector itself stimulated a strong recall CD4 response in all individuals tested, and also induced up-regulation of class I MHC, CD86 and CD40 on the dendritic cell surface. The study provides no evidence that HIV Nef impairs the function of human dendritic cells, and suggests that delivery of Nef to dendritic cells may be one strategy with which to stimulate an HIV-1 immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670336     DOI: 10.1016/j.vaccine.2003.07.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

2.  Immunostimulatory activities of dendritic cells loaded with adenovirus vector carrying HBcAg/HBsAg.

Authors:  Hongyu Jia; Chunling Li; Yimin Zhang; Liang Yu; Dairong Xiang; Jun Liu; Fengzhe Chen; Xiaochun Han
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.

Authors:  Diana Ayinde; Timothée Bruel; Sylvain Cardinaud; Françoise Porrot; Julia G Prado; Arnaud Moris; Olivier Schwartz
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

4.  Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo.

Authors:  W David Wick; Peter B Gilbert; Otto O Yang
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.